Sabrina G. Fayaz, M.S., MCST

---

Cannabinoid Dosing Strategies: Precision, Personalization, and Patient-Centered Care

Sabrina G. Fayaz, M.S., MCST, Director, Master of Science in Medical Cannabinoid Therapeutics (MCT) Program, LECOM

The presentation will align with the video link https://www.youtube.com/watch?v=wxgzE-C-t44 and will be expanded upon by a practicing neurologist with over 15 years of experience consulting on cannabinoid dosing in Pennsylvania.     Effective cannabinoid dosing requires a nuanced understanding of pharmacology, product variability, patient physiology, and formulation‑specific considerations. This presentation provides a practical, evidence‑informed framework for clinicians seeking to optimize therapeutic outcomes while minimizing adverse effects. Beginning with foundational principles of initial dosing for THC and CBD, the session explores inhaled cannabis dosing, including strain‑specific calculations that translate potency and quantity into precise dosage amounts. Participants will then examine best practices for titrating oral, edible, and tincture formulations, with emphasis on patient‑centered strategies that support safe initiation and individualized adjustment.    The presentation highlights real‑world application through a personalized product recommendation example and underscores the importance of structured monitoring, journaling, and follow‑up intervals aligned with best medical practices. By integrating clinical reasoning with practical tools, this session equips learners with the confidence and competence to guide patients through cannabinoid therapy using a systematic, problem‑solving approach.

Professor Sabrina Fayaz serves as the Director of the LECOM Master of Science in Medical Cannabinoid Therapeutics (MCT) program. She brings extensive experience to this role, having spent seven years in retail dispensary operations across medical and recreational cannabis markets in Nevada, Maryland, and Florida. This background provides her with a deep understanding of the complexities and evolving demands of the cannabis industry.    Ms. Fayaz earned her Master’s in Medical Cannabis Science and Therapeutics from the University of Maryland, Baltimore, and holds a Bachelor of Arts in Complementary and Alternative Healthcare from the University of Arizona. Her academic training emphasizes evidence-based therapeutics, systems integration, and cannabis policy, giving her a multidisciplinary perspective on cannabinoid medicine.    She is active in public policy discussions, contributing through the MCST Student Association and the S3 Collective, and has provided public comments on federal cannabis scheduling proposals. Her insights into toxicology, abuse potential, and therapeutic applications reflect her commitment to advancing the field through science and advocacy. Passionate about reducing stigma and empowering future leaders, she is dedicated to education, patient-centered care, and expanding access to credible cannabinoid knowledge.